普利制药 (300630.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(普利制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度销售毛利率(%) 49.0038.0076.0083.0045.0064.0072.00
 单季度销售净利率(%) -22.00-94.0022.00-1.00-2.0012.0031.00
 单季度净资产收益率ROE(%) -1.00-4.002.00--1.003.00
 单季度总资产净利率ROA(%) -1.00-2.001.00--1.001.00
单季度财务摘要:
 单季度营业总收入(元) 187,782,077.00131,134,794.00306,327,292.00681,338,757.00152,793,969.00255,675,662.00214,674,953.00
 单季度营业总成本(元) 265,313,409.00327,166,404.00222,052,786.00531,898,613.00283,265,682.00285,508,496.00200,006,585.00
 单季度营业收入(元) 187,782,077.00131,134,794.00306,327,292.00681,338,757.00152,793,969.00255,675,662.00214,674,953.00
 单季度营业利润(元) -40,227,287.00-173,154,330.0088,428,625.00120,626,196.00-113,848,363.003,921,162.0037,187,689.00
 单季度利润总额(元) -49,232,377.00-176,672,313.0088,456,330.00147,612,122.00-113,987,571.003,988,766.0037,207,007.00
 单季度净利润(元) -41,457,667.00-123,502,933.0066,690,483.00-7,769,219.00-3,260,223.0030,557,063.0066,395,245.00
 单季度归属母公司股东的净利润(元) -41,457,667.00-123,502,933.0066,690,483.00-7,769,219.00-3,260,223.0030,557,063.0066,395,245.00
 单季度经营活动产生的现金流量(元) -67,653,621.005,650,410.00-112,186,504.00-23,918,521.00-43,106,873.00124,819,069.0054,925,466.00
 单季度投资活动产生的现金流量(元) -2,805,630.0070,706,406.00-99,091,011.0063,634,384.00-29,544,642.00-219,194,103.00-380,887,182.00
 单季度筹资活动产生的现金流量(元) -26,789,569.00-58,229,707.00295,327,620.00-116,270,291.0046,462,097.00-68,002,229.00111,094,226.00
 单季度现金及现金等价物净增加(元) -97,331,815.0018,325,833.0083,990,405.00-77,268,462.00-26,278,720.00-160,138,382.00-214,777,883.00

前瞻产业研究院